| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JCEM-43-1-10 |
| P698 | PubMed publication ID | 947930 |
| P2093 | author name string | M. Maeda | |
| H. Ikeda | |||
| Y. Imai | |||
| Y. Masuyama | |||
| N. Kuzuya | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10-17 | |
| P577 | publication date | 1976-07-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism | |
| P478 | volume | 43 |
| Q28303602 | 4 Investigation and treatment of hypothyroidism |
| Q71112523 | An approach to investigation of the changing pattern of plasma cyclic nucleotides and their correlation with thyroid hormone in hyperthyroid patients before and after 131I treatment |
| Q41132262 | Clinical use of sensitive assays for thyroid-stimulating hormone |
| Q70404513 | Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine |
| Q38353508 | Goiter: an approach to management. |
| Q33581207 | Maintenance requirements of L-thyroxine in the treatment of hypothyroidism |
| Q34484544 | Management of patients with congenital hypothyroidism |
| Q43010849 | Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis". |
| Q39546286 | Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy |
| Q39040887 | The emergence of levothyroxine as a treatment for hypothyroidism |
| Q66933572 | The treatment of benign thyroid disease |
| Q67908766 | Thyroid Hormone Use: Trends in the United States from 1960 Through 1988 |
| Q70242675 | Thyroid disease in the elderly |
| Q71538595 | Twenty-four hour variations of triiodothyronine (T3) levels in patients who had thyroid ablation for thyroid cancer, receiving T3 as suppressive treatment |
| Q41391840 | Use of Thyrotropin-Releasing Hormone In Clinical Medicine |
| Q69466610 | Value of free thyroxine (FT4), free triiodothyronine (FT3), and sensitive thyrotropin (TSH) assay in the assessment of optimal thyroxine therapy |
Search more.